IMP3 and cancer: PoTER derives from GCNIS; specifically, it is part of NSGCT [56], it is a malignant tumour that develops metastases like primary teratoma or other germ cell tumours in 22–37% of cases [54] and is characterized by anomalies of chromosome 12p and by IMP3 expression [67,68].